Tarrytown, N.Y.-based Regeneron Pharmaceuticals said the FDA declined to approve its blood cancer therapy for two forms of lymphoma over concerns about the ongoing confirmatory trials.
Author: Mariah Taylor
Tom Purcell, MD, started his career in business consulting, and it was not until he was 28 that he first entered medical school.
Castle Connolly's 2024 accolades honored 13 hospitals and systems for having the most top-rated cancer care physicians.
Clinical trials are top of mind for Abhisek Swaika, MD, including how to improve access and build an infrastructure of care that patients seek, especially in the community setting.
Three Chicago health systems have collaborated with a nonprofit foundation to launch the Chicago Breast Cancer Research Consortium.
It was a feeling of helplessness that led Mark Evers, MD, a gastrointestinal surgeon, to pursue cancer research.
Nearly half of oncologists said they use the internet for more than four hours every day for professional reasons, a recent Medscape survey found.
The Prostate Cancer Foundation released new guidelines for prostate-specific antigen-based screening in Black men.
The cyberattack on Change has some cancer centers scrambling to find money for chemotherapy to avoid delaying treatment, but Change said it plans to have cancer services up and running this week, The New York Times reported March 5.
The FDA approved a new drug for first-line lung cancer treatment.
